What Is the Global Impact of HBV and HCV on Cancer Rates?
The global burden of liver cancer is heavily influenced by HBV and HCV infections. Approximately 80% of liver cancer cases are attributed to these viral infections. HBV is more prevalent in Asia and Africa, while HCV is more common in Europe and the Americas. Vaccination against HBV and antiviral treatments for both HBV and HCV have been effective in reducing the incidence of liver cancer.
